Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7647962rdf:typepubmed:Citationlld:pubmed
pubmed-article:7647962lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:7647962lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7647962lifeskim:mentionsumls-concept:C0228919lld:lifeskim
pubmed-article:7647962lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:7647962lifeskim:mentionsumls-concept:C0753726lld:lifeskim
pubmed-article:7647962lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7647962lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:7647962lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:7647962lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:7647962lifeskim:mentionsumls-concept:C0250717lld:lifeskim
pubmed-article:7647962pubmed:issue1lld:pubmed
pubmed-article:7647962pubmed:dateCreated1995-9-26lld:pubmed
pubmed-article:7647962pubmed:abstractTextNeurogenic oedema formation in the rat hind paw skin induced by electrical stimulation of the saphenous nerve and measured by extravasation of [125I]-albumin, was inhibited by the 5-HT1B receptor agonist, CP-93,129, and the novel tryptamine analogue, CP-122,288. Significant inhibition of up to 66% of control was observed with CP-122,288 (2 x 10(-14) - 2 x 10(-7) mol kg-1) and CP-93,129 (5 x 10(-7) - 5 x 10(-6) mol kg-1), with the minimum effective dose for CP-122,288 being about 10(7) fold less than that for CP-93,129. Oedema formation induced by the intradermal administration of exogenous mediators (substance P and histamine) in rat dorsal skin was not inhibited by CP-122,288 (2 x 10(-10) mol kg-1). These results suggest that CP-122,288 is a potent inhibitor of neurogenic inflammation in rat skin and that the effect may be due to a prejunctional inhibition of neuropeptide release.lld:pubmed
pubmed-article:7647962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:languageenglld:pubmed
pubmed-article:7647962pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:citationSubsetIMlld:pubmed
pubmed-article:7647962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647962pubmed:statusMEDLINElld:pubmed
pubmed-article:7647962pubmed:monthMaylld:pubmed
pubmed-article:7647962pubmed:issn0007-1188lld:pubmed
pubmed-article:7647962pubmed:authorpubmed-author:SheppersonN...lld:pubmed
pubmed-article:7647962pubmed:authorpubmed-author:GuptaPPlld:pubmed
pubmed-article:7647962pubmed:authorpubmed-author:BrainS DSDlld:pubmed
pubmed-article:7647962pubmed:authorpubmed-author:KajekarRRlld:pubmed
pubmed-article:7647962pubmed:issnTypePrintlld:pubmed
pubmed-article:7647962pubmed:volume115lld:pubmed
pubmed-article:7647962pubmed:ownerNLMlld:pubmed
pubmed-article:7647962pubmed:authorsCompleteYlld:pubmed
pubmed-article:7647962pubmed:pagination1-2lld:pubmed
pubmed-article:7647962pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:meshHeadingpubmed-meshheading:7647962-...lld:pubmed
pubmed-article:7647962pubmed:year1995lld:pubmed
pubmed-article:7647962pubmed:articleTitleEffect of a 5-HT1 receptor agonist, CP-122,288, on oedema formation induced by stimulation of the rat saphenous nerve.lld:pubmed
pubmed-article:7647962pubmed:affiliationPharmacology Group, King's College, London.lld:pubmed
pubmed-article:7647962pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7647962pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7647962lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7647962lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7647962lld:pubmed